No Data
No Data
Johnson & Johnson Insiders Sell US$4.8m Of Stock, Possibly Signalling Caution
Johnson & Johnson (JNJ) Stock Falls Amid Market Uptick: What Investors Need to Know
3 Mega Cap Stock Bargains As Markets Hit All-Time Highs
As markets continue to reach new all-time highs, investors are constantly seeking opportunities that offer both stability and growth potential. With the S&P 500 and Nasdaq recently hitting new all-tim
J&J Talc Users Want Cancer Monitoring Even If It Cost Billions
Johnson & Johnson should be on the hook for potentially billions of dollars in medical fees for women who used its talc-based baby powders and want to monitor their future health over cancer fears, according to a lawsuit.
Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst
Shares of cell therapy company Legend Biotech Corp (NASDAQ:LEGN) were trading lower on Monday, after being among the top pharma gainers in the first week of June.The company's Carvykti drug is likely
Market Analysis: Johnson & Johnson And Competitors In Pharmaceuticals Industry
In today's fast-paced and highly competitive business world, it is crucial for investors and industry followers to conduct comprehensive company evaluations. In this article, we will delve into an ext
No Data